Tirdzniecība Takeda Pharmaceutical Company Limited - 4502 CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Tirdzniecības Nosacījumi
| Starpība | 24.12 | ||||||||
|
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.010938% | ||||||||
|
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.011284% | ||||||||
| Nakts laika nodeva | 21:00 (UTC) | ||||||||
| Min. tirgotais daudzums | 1 | ||||||||
| Valūta | JPY | ||||||||
| Drošības rezerve | 20% | ||||||||
| Fondu birža | Japan | ||||||||
| Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Galvenie Statistikas Dati
| Iepriekš. aizvērt* | 4252.6 |
| Atvērt* | 4228.56 |
| Izmaiņas par 1 gadu* | 17.37% |
| Dienas Diapazons* | 4228.56 - 4266.86 |
| 52 ned Diapazons | 3,455.00-4,478.00 |
| Vidējais apjoms (10 dienas) | 5.94M |
| Vidējais apjoms (3 mēneši) | 88.20M |
| Tirgus Kapitalizācija | 6,745.33B |
| Cenas/Peļņas Attiecība | 24.23 |
| Izvietotās Akcijas | 1.55B |
| Ieņēmumi | 3,944.61B |
| EPS | 175.97 |
| Dividende (Ienesīgums %) | 4.22238 |
| Beta | 0.99 |
| Nākamās Peļņas Datums | May 11, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
|---|---|---|---|---|---|---|
| Mar 24, 2023 | 4254.99 | 11.77 | 0.28% | 4243.22 | 4267.86 | 4224.16 |
| Mar 23, 2023 | 4252.60 | -32.31 | -0.75% | 4284.91 | 4286.90 | 4240.03 |
| Mar 22, 2023 | 4358.72 | -55.75 | -1.26% | 4414.47 | 4414.47 | 4352.73 |
| Mar 20, 2023 | 4283.82 | -61.23 | -1.41% | 4345.05 | 4347.74 | 4282.72 |
| Mar 17, 2023 | 4369.09 | 34.51 | 0.80% | 4334.58 | 4382.66 | 4320.91 |
| Mar 16, 2023 | 4273.94 | 6.88 | 0.16% | 4267.06 | 4292.79 | 4244.02 |
| Mar 15, 2023 | 4332.19 | 30.12 | 0.70% | 4302.07 | 4332.19 | 4286.81 |
| Mar 14, 2023 | 4265.46 | 32.02 | 0.76% | 4233.44 | 4293.29 | 4206.11 |
| Mar 13, 2023 | 4279.92 | 5.49 | 0.13% | 4274.43 | 4290.30 | 4240.93 |
| Mar 10, 2023 | 4335.78 | -9.97 | -0.23% | 4345.75 | 4354.23 | 4323.71 |
| Mar 9, 2023 | 4388.64 | 54.76 | 1.26% | 4333.88 | 4390.64 | 4317.82 |
| Mar 8, 2023 | 4323.81 | 31.92 | 0.74% | 4291.89 | 4329.90 | 4289.00 |
| Mar 7, 2023 | 4289.10 | 19.16 | 0.45% | 4269.94 | 4292.89 | 4264.86 |
| Mar 6, 2023 | 4260.97 | 21.94 | 0.52% | 4239.03 | 4269.45 | 4233.94 |
| Mar 3, 2023 | 4237.04 | 46.28 | 1.10% | 4190.76 | 4252.40 | 4190.16 |
| Mar 2, 2023 | 4172.11 | 5.49 | 0.13% | 4166.62 | 4188.56 | 4155.23 |
| Mar 1, 2023 | 4165.22 | -5.09 | -0.12% | 4170.31 | 4191.16 | 4164.13 |
| Feb 28, 2023 | 4195.54 | 28.22 | 0.68% | 4167.32 | 4201.53 | 4166.22 |
| Feb 27, 2023 | 4186.07 | -13.37 | -0.32% | 4199.44 | 4211.11 | 4183.17 |
| Feb 24, 2023 | 4186.07 | -49.07 | -1.16% | 4235.14 | 4235.14 | 4157.63 |
Takeda Pharmaceutical Company Limited Events
| Laiks (UTC) (UTC) | Valsts | Notikums |
|---|---|---|
| No events scheduled | ||
- Ikgadējs
- Ceturkšņa
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 3569010 | 3197810 | 3291190 | 2097220 | 1770530 |
| Ienākumi | 3569010 | 3197810 | 3291190 | 2097220 | 1770530 |
| Cost of Revenue, Total | 1106850 | 994308 | 1089760 | 651729 | 495921 |
| Bruto Peļņa | 2462160 | 2203500 | 2201420 | 1445500 | 1274610 |
| Kopējie Darbības Izdevumi | 3123810 | 2596860 | 3193730 | 1874650 | 1531000 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 886361 | 875663 | 964737 | 717599 | 628106 |
| Pētniecība un Attīstība | 526087 | 455833 | 492381 | 368298 | 325441 |
| Depreciation / Amortization | 472915 | 421864 | 455420 | 178617 | 122131 |
| Neparedzēti Izdevumi (Ienākumi) | 100290 | -265230 | 189043 | -41201 | 28183 |
| Other Operating Expenses, Total | 31309 | 114422 | 2384 | -2507 | -3907 |
| Darbības Izdevumi | 445198 | 600952 | 97459 | 222577 | 239528 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -142628 | -234717 | -158213 | -94965 | -22323 |
| Citi, Neto | 1 | ||||
| Neto Ienākumi Pirms Nodokļu Nomaksas | 302571 | 366235 | -60754 | 127612 | 217205 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | 230166 | 376171 | 44290 | 135080 | 186708 |
| Mazākuma Interese | -107 | -166 | -49 | 112 | 178 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | 230059 | 376005 | 44241 | 135192 | 186886 |
| Neto Ienākumi | 230059 | 376005 | 44241 | 135192 | 186886 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 230059 | 376005 | 44241 | 135192 | 186886 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 230059 | 376005 | 44241 | 135192 | 186886 |
| Atšķaidītie Neto Ienākumi | 230059 | 376005 | 44241 | 135192 | 186886 |
| Atšķaidītie Ienākumi par Akcijām | 1577.17 | 1573.54 | 1566.2 | 966.897 | 786.69 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 145.868 | 238.955 | 28.2473 | 139.82 | 237.56 |
| Dividends per Share - Common Stock Primary Issue | 180 | 180 | 180 | 180 | 180 |
| Atšķaidītā Normalizētā Peļņa par Akciju | 194.24 | 129.394 | 106.703 | 112.123 | 268.355 |
| Procentu Izdevumi (Ienākumi) - Neto Darbība | 2112 | -64872 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 873289 | 901294 | 844819 | 949603 | 770274 |
| Ienākumi | 873289 | 901294 | 844819 | 949603 | 770274 |
| Cost of Revenue, Total | 308380 | 281404 | 275797 | 241264 | 253446 |
| Bruto Peļņa | 564909 | 619890 | 569022 | 708339 | 516828 |
| Kopējie Darbības Izdevumi | 874908 | 784810 | 747392 | 701051 | 619734 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 223429 | 231078 | 212011 | 219843 | 234388 |
| Pētniecība un Attīstība | 143628 | 128378 | 131600 | 122480 | 113289 |
| Depreciation / Amortization | 149283 | 118087 | 102721 | 102824 | 114294 |
| Neparedzēti Izdevumi (Ienākumi) | 33062 | 26767 | 27979 | 16751 | 29440 |
| Other Operating Expenses, Total | 17126 | -904 | -2716 | -2111 | -125123 |
| Darbības Izdevumi | -1619 | 116484 | 97427 | 248552 | 150540 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -52429 | -44291 | -35980 | -25574 | -19662 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | -54047 | 72193 | 61447 | 222978 | 130878 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | -11375 | 57820 | 45995 | 137726 | 197144 |
| Mazākuma Interese | 17 | -51 | -31 | -43 | -46 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | -11358 | 57769 | 45964 | 137683 | 197098 |
| Neto Ienākumi | -11358 | 57769 | 45964 | 137683 | 197098 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -11358 | 57770 | 45964 | 137684 | 197098 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -11358 | 57770 | 45964 | 137684 | 197098 |
| Atšķaidītie Neto Ienākumi | -11358 | 57770 | 45964 | 137684 | 197098 |
| Atšķaidītie Ienākumi par Akcijām | 1553.81 | 1574.97 | 1580.42 | 1574.43 | 1574.48 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -7.30976 | 36.68 | 29.0834 | 87.4503 | 125.183 |
| Dividends per Share - Common Stock Primary Issue | 90 | 0 | 90 | 0 | 90 |
| Atšķaidītā Normalizētā Peļņa par Akciju | 6.52092 | 50.2916 | 42.335 | 94.0219 | 137.337 |
| Total Adjustments to Net Income | 1 | 0 | 1 | ||
| Citi, Neto | 1 |
- Ikgadējs
- Ceturkšņa
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 2593640 | 2712890 | 2469430 | 2993040 | 1078810 |
| Nauda un Īstermiņa Ieguldījumi | 875000 | 1002820 | 653436 | 725819 | 375186 |
| Nauda un Ekvivalenti | 389058 | 335027 | 188640 | 462890 | 243324 |
| Īstermiņa Ieguldījumi | 485942 | 667793 | 464796 | 262929 | 131862 |
| Debitoru Parādu Kopsumma, Neto | 724377 | 812714 | 784921 | 749119 | 428792 |
| Accounts Receivable - Trade, Net | 617518 | 707487 | 670708 | 657681 | 360833 |
| Total Inventory | 853167 | 753881 | 759599 | 919670 | 212944 |
| Other Current Assets, Total | 141098 | 143478 | 271476 | 598429 | 61886 |
| Total Assets | 13178000 | 12912300 | 12821100 | 13792800 | 4106460 |
| Property/Plant/Equipment, Total - Net | 1582800 | 1453920 | 1386370 | 1331930 | 536801 |
| Property/Plant/Equipment, Total - Gross | 2453010 | 2191740 | 2084120 | 1971520 | 1191400 |
| Accumulated Depreciation, Total | -870208 | -737818 | -697754 | -639591 | -654597 |
| Goodwill, Net | 4407750 | 4033920 | 4012530 | 4240250 | 1029250 |
| Intangibles, Net | 3818540 | 3909110 | 4171360 | 4751170 | 1014260 |
| Long Term Investments | 330133 | 348350 | 369455 | 299922 | 304385 |
| Other Long Term Assets, Total | 445150 | 454110 | 411948 | 176463 | 142957 |
| Total Current Liabilities | 2145730 | 1773180 | 2175900 | 2553050 | 737509 |
| Accounts Payable | 295933 | 232105 | 211627 | 212348 | 133705 |
| Notes Payable/Short Term Debt | 285 | 69 | 5014 | 500002 | 18 |
| Current Port. of LT Debt/Capital Leases | 203708 | 22084 | 581803 | 484944 | |
| Other Current Liabilities, Total | 1645800 | 1518920 | 1377450 | 1355760 | 603786 |
| Total Liabilities | 7495000 | 7739260 | 8097610 | 8610790 | 2109040 |
| Total Long Term Debt | 4141420 | 4613220 | 4506490 | 4766000 | 985644 |
| Long Term Debt | 4141420 | 4613220 | 4506490 | 4766000 | 985644 |
| Deferred Income Tax | 473145 | 576542 | 765079 | 783356 | 90725 |
| Minority Interest | 504 | 4140 | 4003 | 4006 | 19985 |
| Other Liabilities, Total | 734202 | 772180 | 646144 | 504372 | 275176 |
| Total Equity | 5683020 | 5173040 | 4723480 | 5181980 | 1997420 |
| Common Stock | 1676260 | 1668140 | 1668120 | 1643580 | 77914 |
| Additional Paid-In Capital | 1708870 | 1688420 | 1680290 | 1650230 | 90740 |
| Retained Earnings (Accumulated Deficit) | 1479720 | 1509910 | 1369970 | 1595430 | 1557310 |
| Treasury Stock - Common | -116007 | -59552 | -87463 | -57142 | -74373 |
| Unrealized Gain (Loss) | 22068 | 41983 | 22891 | 46380 | 73037 |
| Other Equity, Total | 912106 | 324131 | 69673 | 303499 | 272799 |
| Total Liabilities & Shareholders’ Equity | 13178000 | 12912300 | 12821100 | 13792800 | 4106460 |
| Total Common Shares Outstanding | 1550.36 | 1563.36 | 1557.77 | 1554.78 | 781.309 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 2593640 | 2477890 | 2456350 | 2476460 | 2712890 |
| Nauda un Īstermiņa Ieguldījumi | 875000 | 751896 | 633623 | 684850 | 1002820 |
| Nauda un Ekvivalenti | 849695 | 724341 | 607881 | 654920 | 966222 |
| Īstermiņa Ieguldījumi | 25305 | 27555 | 25742 | 29930 | 36598 |
| Debitoru Parādu Kopsumma, Neto | 724377 | 756117 | 887295 | 858957 | 812714 |
| Accounts Receivable - Trade, Net | 696644 | 715515 | 843625 | 827253 | 783091 |
| Total Inventory | 853167 | 811324 | 783476 | 779148 | 753881 |
| Other Current Assets, Total | 141098 | 158556 | 151959 | 153503 | 143478 |
| Total Assets | 13178000 | 12698500 | 12560300 | 12657200 | 12912300 |
| Property/Plant/Equipment, Total - Net | 1582800 | 1493590 | 1459920 | 1452170 | 1453920 |
| Goodwill, Net | 4407750 | 4167990 | 4078370 | 4058940 | 4033920 |
| Intangibles, Net | 3818540 | 3791880 | 3783680 | 3856430 | 3909110 |
| Long Term Investments | 330133 | 334812 | 352091 | 374659 | 348350 |
| Other Long Term Assets, Total | 445150 | 432359 | 429864 | 438578 | 454110 |
| Total Current Liabilities | 2145730 | 1809250 | 1918750 | 1706780 | 1773180 |
| Accounts Payable | 516297 | 351185 | 336600 | 320645 | 343838 |
| Notes Payable/Short Term Debt | 285 | 0 | 0 | 0 | 69 |
| Current Port. of LT Debt/Capital Leases | 203708 | 122936 | 214886 | 24272 | 22084 |
| Other Current Liabilities, Total | 1425440 | 1335130 | 1367260 | 1361860 | 1407180 |
| Total Liabilities | 7495000 | 7367190 | 7236340 | 7418980 | 7739260 |
| Total Long Term Debt | 4141420 | 4231940 | 4016470 | 4381590 | 4613220 |
| Long Term Debt | 4141420 | 4231940 | 4016470 | 4381590 | 4613220 |
| Deferred Income Tax | 473145 | 589481 | 576738 | 578065 | 576542 |
| Minority Interest | 504 | 493 | 426 | 385 | 4140 |
| Other Liabilities, Total | 734202 | 736023 | 723951 | 752155 | 772180 |
| Total Equity | 5683020 | 5331330 | 5323940 | 5238260 | 5173040 |
| Common Stock | 1676260 | 1676260 | 1676260 | 1669120 | 1668140 |
| Additional Paid-In Capital | 1708870 | 1697560 | 1686490 | 1682500 | 1688420 |
| Retained Earnings (Accumulated Deficit) | 1479720 | 1466930 | 1551150 | 1503810 | 1509910 |
| Treasury Stock - Common | -116007 | -91013 | -41037 | -42344 | -59552 |
| Unrealized Gain (Loss) | 22068 | 31196 | 57646 | 41983 | |
| Other Equity, Total | 912106 | 550395 | 451066 | 367516 | 324131 |
| Total Liabilities & Shareholders’ Equity | 13178000 | 12698500 | 12560300 | 12657200 | 12912300 |
| Total Common Shares Outstanding | 1550.36 | 1557.49 | 1572.83 | 1568.66 | 1563.36 |
- Ikgadējs
- Ceturkšņa
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Neto ienākumi/Sākuma Līnija | 230166 | 376171 | 44290 | 109014 | 186708 |
| Nauda no Darbības | 1123100 | 1010930 | 670381 | 328301 | 399200 |
| Nauda no Darbības | 583151 | 559671 | 583649 | 272446 | 182127 |
| Bezskaidras Naudas Preces | 252109 | 12308 | 172928 | 39061 | -43306 |
| Cash Taxes Paid | 140423 | 201687 | 226768 | 44909 | 29883 |
| Samaksātie Procenti Naudā | 108207 | 107350 | 127211 | 34914 | 8365 |
| Izmaiņas Apgrozāmajā Kapitālā | 57679 | 62781 | -130486 | -92220 | 73671 |
| Nauda no Ieguldījumu Darbībām | -198125 | 393530 | 292119 | -2835700 | -93342 |
| Kapitālie Izdevumi | -186037 | -236468 | -217710 | -134114 | -128262 |
| Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -12088 | 629998 | 509829 | -2701580 | 34920 |
| Nauda no Darbībām ar Finansēšanu | -1070260 | -1088350 | -1005210 | 2946240 | -326226 |
| Naudas Plūsma Finansēšanas Posteņos | -108592 | -142352 | -132804 | -71143 | -15099 |
| Total Cash Dividends Paid | -283665 | -283357 | -282582 | -142952 | -141893 |
| Akciju Izsniegšana (Atkāpšanās), Neto | -77531 | -2141 | -3737 | -1172 | -18756 |
| Parādu Izsniegšana (Atkāpšanās), Neto | -600477 | -660504 | -586090 | 3161500 | -150478 |
| Ārvalstu Valūtas Ietekme | 28758 | 12501 | -21766 | -31269 | -4565 |
| Neto Izmaiņas Naudā | -116527 | 328608 | -64479 | 407571 | -24933 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 230166 | 241541 | 183721 | 137726 | 376171 |
| Cash From Operating Activities | 1123100 | 747521 | 400011 | 166858 | 1010930 |
| Cash From Operating Activities | 583151 | 430877 | 283595 | 142948 | 559671 |
| Non-Cash Items | 252109 | 187026 | 112596 | 53003 | 12308 |
| Cash Taxes Paid | 140423 | 101086 | 73872 | 35902 | 201687 |
| Cash Interest Paid | 108207 | 84917 | 52668 | 23218 | 107350 |
| Changes in Working Capital | 57679 | -111923 | -179901 | -166819 | 62781 |
| Cash From Investing Activities | -198125 | -172487 | -103349 | -70445 | 393530 |
| Capital Expenditures | -186037 | -134214 | -85783 | -42292 | -236468 |
| Other Investing Cash Flow Items, Total | -12088 | -38273 | -17566 | -28153 | 629998 |
| Cash From Financing Activities | -1070260 | -826465 | -658405 | -411038 | -1088350 |
| Financing Cash Flow Items | -108592 | -85284 | -52681 | -23218 | -142352 |
| Total Cash Dividends Paid | -283665 | -273024 | -141573 | -132032 | -283357 |
| Issuance (Retirement) of Stock, Net | -77531 | -52538 | -2542 | -2542 | -2141 |
| Issuance (Retirement) of Debt, Net | -600477 | -415619 | -461609 | -253246 | -660504 |
| Foreign Exchange Effects | 28758 | 9549 | 3402 | 3324 | 12501 |
| Net Change in Cash | -116527 | -241882 | -358341 | -311301 | 328608 |
| Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
|---|---|---|---|---|---|---|
| Nomura Asset Management Co., Ltd. | Investment Advisor | 4.1084 | 65007007 | -76000 | 2023-02-28 | LOW |
| Sumitomo Mitsui Trust Asset Management Co., Ltd. | Investment Advisor | 3.8571 | 61030834 | 60935676 | 2022-11-30 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.6684 | 42222686 | 45800 | 2023-02-28 | LOW |
| JPMorgan Securities Japan Co., Ltd. | Research Firm | 2.3848 | 37735000 | 13609000 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.2311 | 35302592 | -811008 | 2023-02-28 | LOW |
| Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 2.0544 | 32507000 | 2470629 | 2022-11-30 | LOW |
| Daiwa Asset Management Co., Ltd. | Investment Advisor | 1.8823 | 29784238 | -48400 | 2023-02-28 | LOW |
| Nippon Life Insurance Company | Insurance Company | 1.861 | 29447000 | -2377000 | 2022-09-30 | LOW |
| Capital Research Global Investors | Investment Advisor | 1.8554 | 29358500 | 18800 | 2023-01-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.5239 | 24113047 | 1171849 | 2022-12-31 | LOW |
| Takeda Science Foundation | Corporation | 1.132 | 17912000 | 0 | 2022-09-30 | LOW |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | Investment Advisor | 0.778 | 12309837 | -65791 | 2023-02-28 | LOW |
| CPP Investment Board | Pension Fund | 0.7341 | 11616000 | 7985000 | 2022-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7089 | 11216737 | 13283 | 2023-02-28 | LOW |
| BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.5202 | 8230678 | 143900 | 2023-02-28 | LOW |
| BlackRock Asset Management Ireland Limited | Investment Advisor | 0.5143 | 8137797 | 8137597 | 2021-06-30 | LOW |
| M & G Investment Management Ltd. | Investment Advisor | 0.4559 | 7213600 | 0 | 2023-01-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.4421 | 6994953 | 16400 | 2023-02-28 | LOW |
| DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.4359 | 6897836 | -59516 | 2023-02-28 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.4172 | 6601449 | 10924 | 2023-01-31 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group500K+
Tirgotāji
92K+
Ikmēneša aktīvie klienti
$53M+
Ikmēneša ieguldījumu apjoms
$30M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
Tirdzniecības komisija
0
- 1:1
Finanšu svira
1:1
- 20
- 100
- 500
- 1000
- 10000
Investīcija
Darījuma apjoms (Kredītplecs x Investīcija):
Atvēršana
Aizvēršana
Īss Garšs
Takeda Pharmaceutical Company Limited Company profile
Par Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited ir Japānā bāzēts uzņēmums, kas galvenokārt nodarbojas ar farmācijas biznesu. Uzņēmums nodarbojas ar farmaceitisko produktu, vispārējās medicīnas produktu, kvazi zāļu un veselības aprūpes produktu pētniecību, izstrādi, ražošanu un pārdošanu Japānā un ārvalstīs. Sabiedrības pētniecības un attīstības funkcijas ir koncentrētas četrās jomās - onkoloģija (vēzis), gremošanas sistēmas slimības, retas slimības un neiroloģija (neiropsihiatriskās slimības), kā arī divās uzņēmējdarbības vienībās - plazmas frakcionēšanas produkti un vakcīnas. Sabiedrība ir iesaistījusies cauruļvadu uzlabošanā pētniecības un attīstības centros, kas galvenokārt atrodas Japānā un Amerikas Savienotajās Valstīs.
| Industry: | Pharmaceuticals (NEC) |
4階
日本橋本町二丁目1番1号
CHUO-KU
TOKYO-TO 103-8668
JP
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com